nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—ADRB1—stomach cancer	0.326	0.366	CbGaD
Nebivolol—HTR1A—stomach cancer	0.292	0.327	CbGaD
Nebivolol—ADRB2—stomach cancer	0.274	0.307	CbGaD
Nebivolol—Syncope—Mitomycin—stomach cancer	0.000938	0.00983	CcSEcCtD
Nebivolol—Loss of consciousness—Mitomycin—stomach cancer	0.000919	0.00964	CcSEcCtD
Nebivolol—Gastrointestinal pain—Floxuridine—stomach cancer	0.00089	0.00932	CcSEcCtD
Nebivolol—Abdominal pain—Floxuridine—stomach cancer	0.00086	0.00901	CcSEcCtD
Nebivolol—Shock—Mitomycin—stomach cancer	0.00084	0.0088	CcSEcCtD
Nebivolol—Thrombocytopenia—Mitomycin—stomach cancer	0.000836	0.00876	CcSEcCtD
Nebivolol—Psoriasis—Methotrexate—stomach cancer	0.000824	0.00863	CcSEcCtD
Nebivolol—Renal failure acute—Irinotecan—stomach cancer	0.000817	0.00856	CcSEcCtD
Nebivolol—Hypersensitivity—Floxuridine—stomach cancer	0.000802	0.0084	CcSEcCtD
Nebivolol—Asthenia—Floxuridine—stomach cancer	0.000781	0.00818	CcSEcCtD
Nebivolol—Psoriasis—Epirubicin—stomach cancer	0.000771	0.00808	CcSEcCtD
Nebivolol—Dyspnoea—Mitomycin—stomach cancer	0.000761	0.00798	CcSEcCtD
Nebivolol—Somnolence—Mitomycin—stomach cancer	0.000759	0.00795	CcSEcCtD
Nebivolol—Diarrhoea—Floxuridine—stomach cancer	0.000744	0.0078	CcSEcCtD
Nebivolol—Fatigue—Mitomycin—stomach cancer	0.000736	0.00771	CcSEcCtD
Nebivolol—Psoriasis—Doxorubicin—stomach cancer	0.000713	0.00748	CcSEcCtD
Nebivolol—Vomiting—Floxuridine—stomach cancer	0.000692	0.00725	CcSEcCtD
Nebivolol—Rash—Floxuridine—stomach cancer	0.000686	0.00719	CcSEcCtD
Nebivolol—Dermatitis—Floxuridine—stomach cancer	0.000685	0.00718	CcSEcCtD
Nebivolol—Headache—Floxuridine—stomach cancer	0.000682	0.00714	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.000679	0.00712	CcSEcCtD
Nebivolol—Nausea—Floxuridine—stomach cancer	0.000646	0.00677	CcSEcCtD
Nebivolol—Asthenia—Mitomycin—stomach cancer	0.000613	0.00642	CcSEcCtD
Nebivolol—Diarrhoea—Mitomycin—stomach cancer	0.000584	0.00612	CcSEcCtD
Nebivolol—Acute coronary syndrome—Irinotecan—stomach cancer	0.000573	0.00601	CcSEcCtD
Nebivolol—Myocardial infarction—Irinotecan—stomach cancer	0.00057	0.00597	CcSEcCtD
Nebivolol—Dizziness—Mitomycin—stomach cancer	0.000565	0.00592	CcSEcCtD
Nebivolol—Acute coronary syndrome—Fluorouracil—stomach cancer	0.000549	0.00575	CcSEcCtD
Nebivolol—Renal failure acute—Capecitabine—stomach cancer	0.000547	0.00573	CcSEcCtD
Nebivolol—Myocardial infarction—Fluorouracil—stomach cancer	0.000546	0.00572	CcSEcCtD
Nebivolol—Vomiting—Mitomycin—stomach cancer	0.000543	0.00569	CcSEcCtD
Nebivolol—Rash—Mitomycin—stomach cancer	0.000538	0.00564	CcSEcCtD
Nebivolol—Dermatitis—Mitomycin—stomach cancer	0.000538	0.00564	CcSEcCtD
Nebivolol—Headache—Mitomycin—stomach cancer	0.000535	0.00561	CcSEcCtD
Nebivolol—Bradycardia—Irinotecan—stomach cancer	0.000531	0.00557	CcSEcCtD
Nebivolol—Nausea—Mitomycin—stomach cancer	0.000507	0.00531	CcSEcCtD
Nebivolol—Atrioventricular block—Epirubicin—stomach cancer	0.0005	0.00524	CcSEcCtD
Nebivolol—Cardiac disorder—Irinotecan—stomach cancer	0.000484	0.00508	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.00047	0.00492	CcSEcCtD
Nebivolol—Atrioventricular block—Doxorubicin—stomach cancer	0.000462	0.00484	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000455	0.00477	CcSEcCtD
Nebivolol—Bronchospasm—Docetaxel—stomach cancer	0.000443	0.00465	CcSEcCtD
Nebivolol—Bronchospasm—Capecitabine—stomach cancer	0.000429	0.0045	CcSEcCtD
Nebivolol—Vertigo—Irinotecan—stomach cancer	0.000408	0.00428	CcSEcCtD
Nebivolol—Syncope—Irinotecan—stomach cancer	0.000407	0.00427	CcSEcCtD
Nebivolol—Renal failure acute—Methotrexate—stomach cancer	0.000407	0.00427	CcSEcCtD
Nebivolol—Loss of consciousness—Irinotecan—stomach cancer	0.000399	0.00418	CcSEcCtD
Nebivolol—Acute coronary syndrome—Docetaxel—stomach cancer	0.000396	0.00415	CcSEcCtD
Nebivolol—Myocardial infarction—Docetaxel—stomach cancer	0.000394	0.00413	CcSEcCtD
Nebivolol—Acute coronary syndrome—Capecitabine—stomach cancer	0.000384	0.00402	CcSEcCtD
Nebivolol—Myocardial infarction—Capecitabine—stomach cancer	0.000381	0.004	CcSEcCtD
Nebivolol—Renal failure acute—Epirubicin—stomach cancer	0.000381	0.00399	CcSEcCtD
Nebivolol—Chest pain—Fluorouracil—stomach cancer	0.00037	0.00388	CcSEcCtD
Nebivolol—Shock—Irinotecan—stomach cancer	0.000365	0.00382	CcSEcCtD
Nebivolol—Nervous system disorder—Irinotecan—stomach cancer	0.000364	0.00381	CcSEcCtD
Nebivolol—Thrombocytopenia—Irinotecan—stomach cancer	0.000363	0.0038	CcSEcCtD
Nebivolol—Bradycardia—Capecitabine—stomach cancer	0.000356	0.00373	CcSEcCtD
Nebivolol—Oedema peripheral—Docetaxel—stomach cancer	0.000355	0.00372	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—stomach cancer	0.000352	0.00369	CcSEcCtD
Nebivolol—Nervous system disorder—Fluorouracil—stomach cancer	0.000348	0.00365	CcSEcCtD
Nebivolol—Thrombocytopenia—Fluorouracil—stomach cancer	0.000348	0.00364	CcSEcCtD
Nebivolol—Oedema peripheral—Capecitabine—stomach cancer	0.000344	0.00361	CcSEcCtD
Nebivolol—Insomnia—Irinotecan—stomach cancer	0.000335	0.00351	CcSEcCtD
Nebivolol—Cardiac disorder—Docetaxel—stomach cancer	0.000335	0.00351	CcSEcCtD
Nebivolol—Paraesthesia—Irinotecan—stomach cancer	0.000333	0.00349	CcSEcCtD
Nebivolol—Dyspnoea—Irinotecan—stomach cancer	0.000331	0.00346	CcSEcCtD
Nebivolol—Somnolence—Irinotecan—stomach cancer	0.00033	0.00345	CcSEcCtD
Nebivolol—Cardiac disorder—Capecitabine—stomach cancer	0.000324	0.0034	CcSEcCtD
Nebivolol—Insomnia—Fluorouracil—stomach cancer	0.000321	0.00337	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00032	0.00335	CcSEcCtD
Nebivolol—Fatigue—Irinotecan—stomach cancer	0.00032	0.00335	CcSEcCtD
Nebivolol—Paraesthesia—Fluorouracil—stomach cancer	0.000319	0.00334	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000317	0.00332	CcSEcCtD
Nebivolol—Dyspnoea—Fluorouracil—stomach cancer	0.000317	0.00332	CcSEcCtD
Nebivolol—Mental disorder—Docetaxel—stomach cancer	0.000316	0.00331	CcSEcCtD
Nebivolol—Somnolence—Fluorouracil—stomach cancer	0.000316	0.00331	CcSEcCtD
Nebivolol—Malnutrition—Docetaxel—stomach cancer	0.000314	0.00329	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000307	0.00321	CcSEcCtD
Nebivolol—Mental disorder—Capecitabine—stomach cancer	0.000306	0.00321	CcSEcCtD
Nebivolol—Malnutrition—Capecitabine—stomach cancer	0.000304	0.00319	CcSEcCtD
Nebivolol—Gastrointestinal pain—Irinotecan—stomach cancer	0.000303	0.00318	CcSEcCtD
Nebivolol—Erectile dysfunction—Methotrexate—stomach cancer	0.000299	0.00314	CcSEcCtD
Nebivolol—Abdominal pain—Irinotecan—stomach cancer	0.000293	0.00307	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000293	0.00307	CcSEcCtD
Nebivolol—Urticaria—Fluorouracil—stomach cancer	0.000282	0.00296	CcSEcCtD
Nebivolol—Syncope—Docetaxel—stomach cancer	0.000282	0.00295	CcSEcCtD
Nebivolol—Loss of consciousness—Docetaxel—stomach cancer	0.000276	0.00289	CcSEcCtD
Nebivolol—Vertigo—Capecitabine—stomach cancer	0.000273	0.00286	CcSEcCtD
Nebivolol—Hypersensitivity—Irinotecan—stomach cancer	0.000273	0.00286	CcSEcCtD
Nebivolol—Syncope—Capecitabine—stomach cancer	0.000273	0.00286	CcSEcCtD
Nebivolol—Chest pain—Docetaxel—stomach cancer	0.000267	0.0028	CcSEcCtD
Nebivolol—Loss of consciousness—Capecitabine—stomach cancer	0.000267	0.0028	CcSEcCtD
Nebivolol—Asthenia—Irinotecan—stomach cancer	0.000266	0.00279	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000266	0.00278	CcSEcCtD
Nebivolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000262	0.00274	CcSEcCtD
Nebivolol—Chest pain—Capecitabine—stomach cancer	0.000259	0.00271	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000257	0.00269	CcSEcCtD
Nebivolol—Diarrhoea—Irinotecan—stomach cancer	0.000254	0.00266	CcSEcCtD
Nebivolol—Shock—Docetaxel—stomach cancer	0.000252	0.00264	CcSEcCtD
Nebivolol—Nervous system disorder—Docetaxel—stomach cancer	0.000251	0.00263	CcSEcCtD
Nebivolol—Pruritus—Fluorouracil—stomach cancer	0.000251	0.00263	CcSEcCtD
Nebivolol—Thrombocytopenia—Docetaxel—stomach cancer	0.000251	0.00263	CcSEcCtD
Nebivolol—Skin disorder—Docetaxel—stomach cancer	0.000249	0.00261	CcSEcCtD
Nebivolol—Bradycardia—Epirubicin—stomach cancer	0.000248	0.0026	CcSEcCtD
Nebivolol—Dizziness—Irinotecan—stomach cancer	0.000245	0.00257	CcSEcCtD
Nebivolol—Shock—Capecitabine—stomach cancer	0.000244	0.00256	CcSEcCtD
Nebivolol—Nervous system disorder—Capecitabine—stomach cancer	0.000243	0.00255	CcSEcCtD
Nebivolol—Diarrhoea—Fluorouracil—stomach cancer	0.000243	0.00255	CcSEcCtD
Nebivolol—Thrombocytopenia—Capecitabine—stomach cancer	0.000243	0.00255	CcSEcCtD
Nebivolol—Cardiac disorder—Methotrexate—stomach cancer	0.000241	0.00253	CcSEcCtD
Nebivolol—Skin disorder—Capecitabine—stomach cancer	0.000241	0.00253	CcSEcCtD
Nebivolol—Oedema peripheral—Epirubicin—stomach cancer	0.00024	0.00251	CcSEcCtD
Nebivolol—Vomiting—Irinotecan—stomach cancer	0.000236	0.00247	CcSEcCtD
Nebivolol—Dizziness—Fluorouracil—stomach cancer	0.000235	0.00246	CcSEcCtD
Nebivolol—Rash—Irinotecan—stomach cancer	0.000234	0.00245	CcSEcCtD
Nebivolol—Dermatitis—Irinotecan—stomach cancer	0.000234	0.00245	CcSEcCtD
Nebivolol—Headache—Irinotecan—stomach cancer	0.000232	0.00243	CcSEcCtD
Nebivolol—Insomnia—Docetaxel—stomach cancer	0.000232	0.00243	CcSEcCtD
Nebivolol—Paraesthesia—Docetaxel—stomach cancer	0.00023	0.00241	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—stomach cancer	0.000229	0.0024	CcSEcCtD
Nebivolol—Dyspnoea—Docetaxel—stomach cancer	0.000228	0.00239	CcSEcCtD
Nebivolol—Somnolence—Docetaxel—stomach cancer	0.000228	0.00239	CcSEcCtD
Nebivolol—Mental disorder—Methotrexate—stomach cancer	0.000228	0.00239	CcSEcCtD
Nebivolol—Malnutrition—Methotrexate—stomach cancer	0.000226	0.00237	CcSEcCtD
Nebivolol—Cardiac disorder—Epirubicin—stomach cancer	0.000226	0.00237	CcSEcCtD
Nebivolol—Vomiting—Fluorouracil—stomach cancer	0.000226	0.00237	CcSEcCtD
Nebivolol—Insomnia—Capecitabine—stomach cancer	0.000224	0.00235	CcSEcCtD
Nebivolol—Rash—Fluorouracil—stomach cancer	0.000224	0.00235	CcSEcCtD
Nebivolol—Dermatitis—Fluorouracil—stomach cancer	0.000224	0.00234	CcSEcCtD
Nebivolol—Paraesthesia—Capecitabine—stomach cancer	0.000223	0.00234	CcSEcCtD
Nebivolol—Headache—Fluorouracil—stomach cancer	0.000222	0.00233	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—stomach cancer	0.000222	0.00232	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000221	0.00232	CcSEcCtD
Nebivolol—Dyspnoea—Capecitabine—stomach cancer	0.000221	0.00232	CcSEcCtD
Nebivolol—Fatigue—Docetaxel—stomach cancer	0.000221	0.00232	CcSEcCtD
Nebivolol—Nausea—Irinotecan—stomach cancer	0.00022	0.00231	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000214	0.00225	CcSEcCtD
Nebivolol—Fatigue—Capecitabine—stomach cancer	0.000214	0.00224	CcSEcCtD
Nebivolol—Mental disorder—Epirubicin—stomach cancer	0.000213	0.00223	CcSEcCtD
Nebivolol—Malnutrition—Epirubicin—stomach cancer	0.000212	0.00222	CcSEcCtD
Nebivolol—Nausea—Fluorouracil—stomach cancer	0.000211	0.00221	CcSEcCtD
Nebivolol—Gastrointestinal pain—Docetaxel—stomach cancer	0.00021	0.0022	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—stomach cancer	0.000209	0.00219	CcSEcCtD
Nebivolol—Vertigo—Methotrexate—stomach cancer	0.000203	0.00213	CcSEcCtD
Nebivolol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000203	0.00213	CcSEcCtD
Nebivolol—Abdominal pain—Docetaxel—stomach cancer	0.000203	0.00212	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—stomach cancer	0.000197	0.00207	CcSEcCtD
Nebivolol—Urticaria—Capecitabine—stomach cancer	0.000197	0.00207	CcSEcCtD
Nebivolol—Abdominal pain—Capecitabine—stomach cancer	0.000196	0.00206	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—stomach cancer	0.000196	0.00205	CcSEcCtD
Nebivolol—Chest pain—Methotrexate—stomach cancer	0.000193	0.00202	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000191	0.00201	CcSEcCtD
Nebivolol—Vertigo—Epirubicin—stomach cancer	0.00019	0.00199	CcSEcCtD
Nebivolol—Syncope—Epirubicin—stomach cancer	0.00019	0.00199	CcSEcCtD
Nebivolol—Hypersensitivity—Docetaxel—stomach cancer	0.000189	0.00198	CcSEcCtD
Nebivolol—Loss of consciousness—Epirubicin—stomach cancer	0.000186	0.00195	CcSEcCtD
Nebivolol—Asthenia—Docetaxel—stomach cancer	0.000184	0.00193	CcSEcCtD
Nebivolol—Hypersensitivity—Capecitabine—stomach cancer	0.000183	0.00192	CcSEcCtD
Nebivolol—Pruritus—Docetaxel—stomach cancer	0.000181	0.0019	CcSEcCtD
Nebivolol—Nervous system disorder—Methotrexate—stomach cancer	0.000181	0.0019	CcSEcCtD
Nebivolol—Thrombocytopenia—Methotrexate—stomach cancer	0.000181	0.0019	CcSEcCtD
Nebivolol—Chest pain—Epirubicin—stomach cancer	0.00018	0.00189	CcSEcCtD
Nebivolol—Skin disorder—Methotrexate—stomach cancer	0.000179	0.00188	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000179	0.00188	CcSEcCtD
Nebivolol—Asthenia—Capecitabine—stomach cancer	0.000178	0.00187	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—stomach cancer	0.000176	0.00185	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—stomach cancer	0.000176	0.00184	CcSEcCtD
Nebivolol—Pruritus—Capecitabine—stomach cancer	0.000176	0.00184	CcSEcCtD
Nebivolol—Diarrhoea—Docetaxel—stomach cancer	0.000175	0.00184	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—stomach cancer	0.000172	0.00181	CcSEcCtD
Nebivolol—Shock—Epirubicin—stomach cancer	0.00017	0.00178	CcSEcCtD
Nebivolol—Diarrhoea—Capecitabine—stomach cancer	0.00017	0.00178	CcSEcCtD
Nebivolol—Nervous system disorder—Epirubicin—stomach cancer	0.00017	0.00178	CcSEcCtD
Nebivolol—Dizziness—Docetaxel—stomach cancer	0.000169	0.00178	CcSEcCtD
Nebivolol—Thrombocytopenia—Epirubicin—stomach cancer	0.000169	0.00177	CcSEcCtD
Nebivolol—Skin disorder—Epirubicin—stomach cancer	0.000168	0.00176	CcSEcCtD
Nebivolol—Insomnia—Methotrexate—stomach cancer	0.000167	0.00175	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—stomach cancer	0.000167	0.00175	CcSEcCtD
Nebivolol—Paraesthesia—Methotrexate—stomach cancer	0.000166	0.00174	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000166	0.00174	CcSEcCtD
Nebivolol—Dyspnoea—Methotrexate—stomach cancer	0.000165	0.00173	CcSEcCtD
Nebivolol—Somnolence—Methotrexate—stomach cancer	0.000164	0.00172	CcSEcCtD
Nebivolol—Dizziness—Capecitabine—stomach cancer	0.000164	0.00172	CcSEcCtD
Nebivolol—Vomiting—Docetaxel—stomach cancer	0.000163	0.00171	CcSEcCtD
Nebivolol—Rash—Docetaxel—stomach cancer	0.000162	0.00169	CcSEcCtD
Nebivolol—Dermatitis—Docetaxel—stomach cancer	0.000161	0.00169	CcSEcCtD
Nebivolol—Headache—Docetaxel—stomach cancer	0.000161	0.00168	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000159	0.00167	CcSEcCtD
Nebivolol—Fatigue—Methotrexate—stomach cancer	0.000159	0.00167	CcSEcCtD
Nebivolol—Vomiting—Capecitabine—stomach cancer	0.000158	0.00165	CcSEcCtD
Nebivolol—Shock—Doxorubicin—stomach cancer	0.000157	0.00165	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—stomach cancer	0.000157	0.00164	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—stomach cancer	0.000157	0.00164	CcSEcCtD
Nebivolol—Rash—Capecitabine—stomach cancer	0.000156	0.00164	CcSEcCtD
Nebivolol—Insomnia—Epirubicin—stomach cancer	0.000156	0.00164	CcSEcCtD
Nebivolol—Dermatitis—Capecitabine—stomach cancer	0.000156	0.00164	CcSEcCtD
Nebivolol—Headache—Capecitabine—stomach cancer	0.000155	0.00163	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—stomach cancer	0.000155	0.00163	CcSEcCtD
Nebivolol—Paraesthesia—Epirubicin—stomach cancer	0.000155	0.00163	CcSEcCtD
Nebivolol—Dyspnoea—Epirubicin—stomach cancer	0.000154	0.00162	CcSEcCtD
Nebivolol—Somnolence—Epirubicin—stomach cancer	0.000154	0.00161	CcSEcCtD
Nebivolol—Nausea—Docetaxel—stomach cancer	0.000152	0.0016	CcSEcCtD
Nebivolol—Gastrointestinal pain—Methotrexate—stomach cancer	0.000151	0.00158	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000149	0.00156	CcSEcCtD
Nebivolol—Fatigue—Epirubicin—stomach cancer	0.000149	0.00156	CcSEcCtD
Nebivolol—Nausea—Capecitabine—stomach cancer	0.000147	0.00154	CcSEcCtD
Nebivolol—Urticaria—Methotrexate—stomach cancer	0.000147	0.00154	CcSEcCtD
Nebivolol—Abdominal pain—Methotrexate—stomach cancer	0.000146	0.00153	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—stomach cancer	0.000145	0.00152	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—stomach cancer	0.000144	0.00151	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—stomach cancer	0.000143	0.00149	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—stomach cancer	0.000142	0.00149	CcSEcCtD
Nebivolol—Gastrointestinal pain—Epirubicin—stomach cancer	0.000141	0.00148	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000138	0.00145	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—stomach cancer	0.000138	0.00145	CcSEcCtD
Nebivolol—Urticaria—Epirubicin—stomach cancer	0.000137	0.00144	CcSEcCtD
Nebivolol—Abdominal pain—Epirubicin—stomach cancer	0.000137	0.00143	CcSEcCtD
Nebivolol—Hypersensitivity—Methotrexate—stomach cancer	0.000136	0.00143	CcSEcCtD
Nebivolol—Asthenia—Methotrexate—stomach cancer	0.000133	0.00139	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000131	0.00137	CcSEcCtD
Nebivolol—Pruritus—Methotrexate—stomach cancer	0.000131	0.00137	CcSEcCtD
Nebivolol—Hypersensitivity—Epirubicin—stomach cancer	0.000127	0.00133	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—stomach cancer	0.000127	0.00133	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—stomach cancer	0.000126	0.00133	CcSEcCtD
Nebivolol—Diarrhoea—Methotrexate—stomach cancer	0.000126	0.00132	CcSEcCtD
Nebivolol—Asthenia—Epirubicin—stomach cancer	0.000124	0.0013	CcSEcCtD
Nebivolol—Pruritus—Epirubicin—stomach cancer	0.000122	0.00128	CcSEcCtD
Nebivolol—Dizziness—Methotrexate—stomach cancer	0.000122	0.00128	CcSEcCtD
Nebivolol—Diarrhoea—Epirubicin—stomach cancer	0.000118	0.00124	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—stomach cancer	0.000118	0.00124	CcSEcCtD
Nebivolol—Vomiting—Methotrexate—stomach cancer	0.000117	0.00123	CcSEcCtD
Nebivolol—Rash—Methotrexate—stomach cancer	0.000116	0.00122	CcSEcCtD
Nebivolol—Dermatitis—Methotrexate—stomach cancer	0.000116	0.00122	CcSEcCtD
Nebivolol—Headache—Methotrexate—stomach cancer	0.000116	0.00121	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—stomach cancer	0.000115	0.0012	CcSEcCtD
Nebivolol—Dizziness—Epirubicin—stomach cancer	0.000114	0.0012	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—stomach cancer	0.000113	0.00119	CcSEcCtD
Nebivolol—Vomiting—Epirubicin—stomach cancer	0.00011	0.00115	CcSEcCtD
Nebivolol—Nausea—Methotrexate—stomach cancer	0.00011	0.00115	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—stomach cancer	0.000109	0.00115	CcSEcCtD
Nebivolol—Rash—Epirubicin—stomach cancer	0.000109	0.00114	CcSEcCtD
Nebivolol—Dermatitis—Epirubicin—stomach cancer	0.000109	0.00114	CcSEcCtD
Nebivolol—Headache—Epirubicin—stomach cancer	0.000108	0.00114	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—stomach cancer	0.000106	0.00111	CcSEcCtD
Nebivolol—Nausea—Epirubicin—stomach cancer	0.000103	0.00108	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—stomach cancer	0.000102	0.00107	CcSEcCtD
Nebivolol—Rash—Doxorubicin—stomach cancer	0.000101	0.00106	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—stomach cancer	0.000101	0.00106	CcSEcCtD
Nebivolol—Headache—Doxorubicin—stomach cancer	0.0001	0.00105	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—stomach cancer	9.5e-05	0.000996	CcSEcCtD
Nebivolol—CYP2D6—Metabolism—PGLS—stomach cancer	1.14e-05	0.00091	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—BLVRB—stomach cancer	1.14e-05	0.00091	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FST—stomach cancer	1.12e-05	0.000892	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	1.11e-05	0.000887	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	1.09e-05	0.000873	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FST—stomach cancer	1.09e-05	0.000873	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPAP2A—stomach cancer	1.09e-05	0.000868	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	1.08e-05	0.000861	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GAST—stomach cancer	1.08e-05	0.000861	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	1.07e-05	0.000854	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FST—stomach cancer	1.07e-05	0.000853	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRB2—stomach cancer	1.06e-05	0.000848	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GAST—stomach cancer	1.05e-05	0.000842	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	1.05e-05	0.000842	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HBEGF—stomach cancer	1.04e-05	0.000835	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RGS2—stomach cancer	1.03e-05	0.000823	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GAST—stomach cancer	1.03e-05	0.000823	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGG—stomach cancer	1.02e-05	0.000816	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	1.01e-05	0.000805	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGG—stomach cancer	9.98e-06	0.000798	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	9.87e-06	0.000789	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	9.82e-06	0.000785	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGG—stomach cancer	9.76e-06	0.00078	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CKB—stomach cancer	9.68e-06	0.000774	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CA1—stomach cancer	9.68e-06	0.000774	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FBP1—stomach cancer	9.68e-06	0.000774	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NDUFA2—stomach cancer	9.68e-06	0.000774	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	9.66e-06	0.000772	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRB2—stomach cancer	9.64e-06	0.00077	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	9.61e-06	0.000768	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	9.49e-06	0.000758	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	9.48e-06	0.000758	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PPP2R1A—stomach cancer	9.44e-06	0.000755	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKAA1—stomach cancer	9.4e-06	0.000751	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	9.28e-06	0.000742	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	9.28e-06	0.000741	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLIN2—stomach cancer	9.1e-06	0.000727	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RBP4—stomach cancer	9.08e-06	0.000725	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCL8—stomach cancer	9.07e-06	0.000725	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CA2—stomach cancer	8.85e-06	0.000708	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PGAM1—stomach cancer	8.63e-06	0.00069	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NT5E—stomach cancer	8.63e-06	0.00069	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLCE1—stomach cancer	8.23e-06	0.000658	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	8.23e-06	0.000658	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	8.16e-06	0.000652	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	8.16e-06	0.000652	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	8.07e-06	0.000645	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—F2R—stomach cancer	8.07e-06	0.000645	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	7.98e-06	0.000638	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	7.98e-06	0.000638	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	7.94e-06	0.000634	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—F2R—stomach cancer	7.89e-06	0.000631	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	7.89e-06	0.000631	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—UMPS—stomach cancer	7.89e-06	0.000631	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	7.85e-06	0.000628	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HSPB1—stomach cancer	7.8e-06	0.000624	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR2—stomach cancer	7.8e-06	0.000624	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	7.76e-06	0.000621	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—BMP2—stomach cancer	7.72e-06	0.000617	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—F2R—stomach cancer	7.72e-06	0.000617	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	7.68e-06	0.000614	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	7.6e-06	0.000608	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKR1C3—stomach cancer	7.59e-06	0.000607	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	7.59e-06	0.000606	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	7.44e-06	0.000595	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	7.42e-06	0.000593	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PDHA1—stomach cancer	7.33e-06	0.000586	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ECHS1—stomach cancer	7.33e-06	0.000586	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PRKCB—stomach cancer	7.27e-06	0.000581	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ANXA1—stomach cancer	7.26e-06	0.00058	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	7.19e-06	0.000574	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB1—stomach cancer	7.03e-06	0.000562	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	7.02e-06	0.000561	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	6.91e-06	0.000552	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FADS1—stomach cancer	6.9e-06	0.000551	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TYMP—stomach cancer	6.9e-06	0.000551	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	6.88e-06	0.00055	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	6.87e-06	0.000549	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	6.76e-06	0.00054	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	6.73e-06	0.000538	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RPS6—stomach cancer	6.71e-06	0.000537	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PRKCB—stomach cancer	6.61e-06	0.000528	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6ST—stomach cancer	6.58e-06	0.000526	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SREBF2—stomach cancer	6.46e-06	0.000516	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	6.45e-06	0.000516	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—RORA—stomach cancer	6.38e-06	0.00051	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	6.31e-06	0.000504	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HBEGF—stomach cancer	6.17e-06	0.000493	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	6.14e-06	0.000491	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	6.1e-06	0.000488	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	6e-06	0.00048	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDOB—stomach cancer	5.98e-06	0.000478	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	5.97e-06	0.000477	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	5.95e-06	0.000476	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6R—stomach cancer	5.87e-06	0.000469	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	5.84e-06	0.000467	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	5.83e-06	0.000466	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	5.71e-06	0.000456	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB2—stomach cancer	5.69e-06	0.000455	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	5.58e-06	0.000446	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALOX5—stomach cancer	5.56e-06	0.000444	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	5.54e-06	0.000443	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DPYD—stomach cancer	5.47e-06	0.000437	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	5.42e-06	0.000433	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	5.42e-06	0.000433	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	5.36e-06	0.000428	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—RHOA—stomach cancer	5.3e-06	0.000424	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	5.3e-06	0.000423	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	5.24e-06	0.000419	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SMAD4—stomach cancer	5.18e-06	0.000414	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FYN—stomach cancer	5.14e-06	0.000411	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	5.13e-06	0.00041	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FYN—stomach cancer	5.03e-06	0.000402	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FYN—stomach cancer	4.92e-06	0.000393	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	4.87e-06	0.000389	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTT1—stomach cancer	4.84e-06	0.000387	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	4.83e-06	0.000386	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	4.78e-06	0.000382	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.76e-06	0.00038	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.72e-06	0.000377	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	4.65e-06	0.000372	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.65e-06	0.000372	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGFR2—stomach cancer	4.62e-06	0.000369	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ENO1—stomach cancer	4.53e-06	0.000362	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.42e-06	0.000353	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	4.32e-06	0.000346	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	4.29e-06	0.000343	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	4.28e-06	0.000342	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IRS2—stomach cancer	4.23e-06	0.000338	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	4.19e-06	0.000335	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	4.18e-06	0.000334	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CAV1—stomach cancer	4.1e-06	0.000328	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—stomach cancer	4.09e-06	0.000327	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.08e-06	0.000326	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	4.06e-06	0.000325	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD44—stomach cancer	4.02e-06	0.000321	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	3.99e-06	0.000319	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	3.97e-06	0.000318	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APC—stomach cancer	3.9e-06	0.000312	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCB—stomach cancer	3.9e-06	0.000312	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6ST—stomach cancer	3.89e-06	0.000311	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APC—stomach cancer	3.82e-06	0.000305	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.74e-06	0.000299	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APC—stomach cancer	3.73e-06	0.000298	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.66e-06	0.000292	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.62e-06	0.00029	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	3.58e-06	0.000286	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.56e-06	0.000284	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.56e-06	0.000284	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.55e-06	0.000283	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3.48e-06	0.000278	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3.48e-06	0.000278	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6R—stomach cancer	3.47e-06	0.000277	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.42e-06	0.000273	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	3.4e-06	0.000272	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—stomach cancer	3.4e-06	0.000272	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.4e-06	0.000272	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.39e-06	0.000271	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.36e-06	0.000269	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTP1—stomach cancer	3.35e-06	0.000268	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.33e-06	0.000266	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.32e-06	0.000265	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—stomach cancer	3.31e-06	0.000264	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.29e-06	0.000263	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.27e-06	0.000262	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	3.25e-06	0.00026	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	3.25e-06	0.00026	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.24e-06	0.000259	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—KRAS—stomach cancer	3.21e-06	0.000257	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	3.2e-06	0.000256	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	3.17e-06	0.000253	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RHOA—stomach cancer	3.13e-06	0.00025	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TYMS—stomach cancer	3.12e-06	0.000249	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—stomach cancer	3.1e-06	0.000248	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.09e-06	0.000247	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—stomach cancer	3.08e-06	0.000246	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	3.03e-06	0.000242	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	3.02e-06	0.000241	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	2.97e-06	0.000237	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	2.95e-06	0.000236	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB2—stomach cancer	2.9e-06	0.000232	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ERCC2—stomach cancer	2.9e-06	0.000231	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	2.87e-06	0.00023	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.86e-06	0.000228	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.81e-06	0.000225	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.81e-06	0.000224	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.79e-06	0.000223	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—stomach cancer	2.75e-06	0.00022	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.75e-06	0.00022	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.73e-06	0.000218	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HRAS—stomach cancer	2.73e-06	0.000218	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—stomach cancer	2.72e-06	0.000218	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	2.69e-06	0.000215	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.68e-06	0.000214	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.67e-06	0.000214	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.67e-06	0.000214	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.62e-06	0.000209	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—stomach cancer	2.61e-06	0.000209	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.61e-06	0.000209	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.6e-06	0.000208	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.59e-06	0.000207	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCND1—stomach cancer	2.56e-06	0.000205	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JUN—stomach cancer	2.56e-06	0.000204	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.54e-06	0.000203	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.53e-06	0.000203	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.53e-06	0.000202	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAV1—stomach cancer	2.51e-06	0.000201	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—stomach cancer	2.51e-06	0.0002	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—stomach cancer	2.49e-06	0.000199	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	2.48e-06	0.000198	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.47e-06	0.000198	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK8—stomach cancer	2.42e-06	0.000193	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.33e-06	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.31e-06	0.000185	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.28e-06	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.26e-06	0.000181	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.23e-06	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.21e-06	0.000177	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.21e-06	0.000177	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—stomach cancer	2.21e-06	0.000176	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.16e-06	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MYC—stomach cancer	2.15e-06	0.000172	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.11e-06	0.000169	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.1e-06	0.000168	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MYC—stomach cancer	2.1e-06	0.000168	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.1e-06	0.000168	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.06e-06	0.000164	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.06e-06	0.000164	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MYC—stomach cancer	2.05e-06	0.000164	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.01e-06	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.01e-06	0.000161	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.98e-06	0.000159	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—stomach cancer	1.98e-06	0.000159	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.94e-06	0.000155	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—stomach cancer	1.9e-06	0.000152	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KRAS—stomach cancer	1.9e-06	0.000152	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.82e-06	0.000146	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.78e-06	0.000143	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.76e-06	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	1.74e-06	0.000139	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—stomach cancer	1.74e-06	0.000139	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.73e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—stomach cancer	1.69e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.69e-06	0.000135	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.65e-06	0.000132	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.61e-06	0.000129	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.61e-06	0.000129	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.58e-06	0.000126	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—stomach cancer	1.54e-06	0.000123	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.07e-06	8.54e-05	CbGpPWpGaD
